Clinical Trial Update: 2 Year Follow up of COSGOD III

View source ↗

Summary

A two-year follow-up update for the COSGOD III clinical trial; the study conducted by Medical University of Graz is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurodevelopmental Disorders

Snippet

Sponsor: Medical University of Graz | Conditions: Neurodevelopmental Disability, Death | Status: COMPLETED